Alpha Teknova, Inc. (TKNO) stock
TKNONasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/30145% above fair value
$8.21−0.08 (-1.02%)
Close on Nov 13, 2026Market cap $440.78MP/E –Yield –
Alpha Teknova price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Alpha Teknova's price to book ratio was 7.4× on Nov 11, 2026, against 3.4× a year earlier. Over the last 5 years it ranged from 0.5× to 7.6×, with a median of 2.3×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 7.4× | +4.6 |
| 2025 | Dec 31, 2025 | 2.8× | −2.3 |
| 2024 | Dec 31, 2024 | 5.1× | +3.6 |
| 2023 | Dec 29, 2023 | 1.5× | +0.1 |
| 2022 | Dec 30, 2022 | 1.4× | −2.5 |
| 2021 | Dec 31, 2021 | 3.9× | – |
See a number that looks wrong?